PATENT CLAIM ANALYSIS

Application Number: 16257527
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "005500"]

Abstract:
The present invention relates to collagen hydrolysate as an active substance for treating sarcopenia, as an active substance against the degenerative loss of muscle mass and for improving muscle power, as an active substance for reducing the age-related loss of muscle mass, and as an active substance for stimulating the conversion of body fat mass to muscle mass. The invention further relates to a method for treating sarcopenia, comprising the repeated oral administration of collagen hydrolysate to a patient.

Claim (Index 21):
A method for stimulating conversion of body fat mass into muscle mass in a patient, the method comprising orally administering collagen hydrolysate to the patient repeatedly.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 99.0
- Lexical Diversity: 2.125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12304356', '14786238', '12013269', '14897176', '14900021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.687005506999275
- 35 USC 102 Novelty (BERT): 0.506357363449023
- Combined Prediction Score: 0.6689406926442497
- Mean Citation Score: 166.51905200000004
- Max Citation Score: 180.64201
- Similarity Product: 108.21198915639044

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test